The Gross Margin of Aurobindo Pharma Ltd (AUROPHARMA.NS) is 52.90%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 52.90% |
| 2023-03-31 | 50.41% |
| 2022-03-31 | 52.87% |
| 2021-03-31 | 56.39% |
| 2020-03-31 | 54.06% |
| 2019-03-31 | 51.19% |
| 2018-03-31 | 54.95% |
| 2017-03-31 | 51.73% |
| 2016-03-31 | 50.09% |
| 2015-03-31 | 49.53% |